Home › Funds › KEATING INVESTMENT COUNSELORS INC › GSK
KEATING INVESTMENT COUNSELORS INC position in GSK
GSK PLC · Health Care
KEATING INVESTMENT COUNSELORS INC reported holding 166,303 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 2.10% of its reported portfolio and ranking #12 among its reported holdings. KEATING INVESTMENT COUNSELORS INC has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How KEATING INVESTMENT COUNSELORS INC's GSK position evolved
KEATING INVESTMENT COUNSELORS INC first disclosed a stake in GSK in Q4 2024 at 163,605 shares (US$5.5M). The position peaked in Q1 2026 at 175,168 shares, worth US$9.7M. Across 8 filings, KEATING INVESTMENT COUNSELORS INC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 166,303 shares valued at US$8.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 163.60K | $5.53M | New |
| Q1 2025 | 188.81K | $7.31M | Add |
| Q2 2025 | 186.80K | $7.17M | Reduce |
| Q3 2025 | 179.53K | $7.75M | Reduce |
| Q4 2025 | 180.11K | $8.83M | Hold |
| Q1 2026 | 175.17K | $9.67M | Reduce |
| Q2 2026 | 166.82K | $8.74M | Reduce |
| Q3 2026 | 166.30K | $8.01M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on KEATING INVESTMENT COUNSELORS INC
FAQ
How long has KEATING INVESTMENT COUNSELORS INC held GSK?
KEATING INVESTMENT COUNSELORS INC has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is KEATING INVESTMENT COUNSELORS INC's current position in GSK?
As of Q3 2026, KEATING INVESTMENT COUNSELORS INC holds 166.30K shares of GSK (GSK PLC), valued at $8.01M, representing 2.10% of its reported portfolio and ranking #12.
Has KEATING INVESTMENT COUNSELORS INC been buying or selling GSK?
In the latest 13F filing (Q3 2026), KEATING INVESTMENT COUNSELORS INC held unchanged its position in GSK. The position peaked in Q1 2026 at 175.17K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.